Oct 2026· Archives of Physiology and Biochemistry· pp.
1-23
· 0 citations· 49 references
Medicine
TL;DR
Overall, acitretin emerged as a computationally prioritised candidate for GSK3-β inhibition studies, but these findings remain computational predictions and require confirmation through experimental GSK3-β inhibition studies.
Abstract
Background: GSK3-β is a serine/threonine kinase involved in metabolic, inflammatory, oncogenic, and neurological signalling pathways. Methods: This study investigated curcumin and ten structurally similar compounds using an integrated in silico approach combining structural similarity screening, molecular docking, MD simulations, DFT calculations, ADMET/toxicity prediction, and network pharmacology. Results: Molecular docking identified phenothrin (-8.3 kcal/mol), acitretin (-8.0 kcal/mol), and curcumin (-7.5 kcal/mol) as the highest-ranking compounds, which were subsequently subjected to three independent 100-ns MD simulations. MD analyses indicated stable protein-ligand complexes, with acitretin showing a persistent and diverse interaction profile within the GSK3-β binding region. Comparative DFT analysis indicated distinct electronic characteristics among the three compounds, while ADMET profiling highlighted differences in their predicted pharmacokinetic and toxicological properties. Network pharmacology predictions associated acitretin-related targets with PPAR, PI3K-Akt, and other signalling pathways. Conclusion: Overall, acitretin emerged as a computationally prioritised candidate. However, these findings remain computational predictions and require confirmation through experimental GSK3-β inhibition studies.
The findings of this study suggest that Hit1 could be a promising multi-target molecule capable of modulating cholinergic transmission, neuronal survival pathways, and oxidative stress in AD.
D. O. Onwu, R. Oria, Y. A. Adekunle et al.· Naunyn-Schmiedeberg's Archiv...· 0 citations
An integrative in-silico pipeline supports the XN-MT conjugate as a potential candidate for further in-vitro studies and preclinical development in breast cancer therapy targeting CDK4.
V. Harish, Sharfuddin Mohd, Goparaju Kavya et al.· Journal of Computational Bio...· 0 citations
Flavonoid activators of AMP-activated protein kinase (AMPK) are emerging as promising modulators of neurodegenerative disease–relevant pathways, yet a systematic, multi-level in silico comparison of candidate molecules is lacking. This study presents the first integrated computational pipeline that combines pharmacokin...
Bindiya Upadhyay, M. Jain· Discover Applied Sciences· 0 citations
The combined evaluation of dual‐target binding and pharmacokinetic profiling highlights the potential of n‐alkoxy chalcone derivatives as multifunctional neuroactive candidates and provides a rational basis for further experimental validation.
Mohammed H. Alheety, M. A. Guma, Mustafa A. Alheety et al.· Macromolecular Symposia· 0 citations
This study combined systems pharmacology and computational biology to systematically investigate the multi-target mechanisms and network features of Astilbin, a natural flavonoid glycoside, in Alzheimer's disease (AD) intervention. We collected potential targets of astilbin and AD-associated genes from PharmGKB, GeneCa...